Literature DB >> 28471774

Adapting Cognitive Task Analysis to Investigate Clinical Decision Making and Medication Safety Incidents.

Alissa L Russ1,2,3,4, Laura G Militello5, Peter A Glassman6, Karen J Arthur3, Alan J Zillich1,2, Michael Weiner1,3,4.   

Abstract

OBJECTIVES: Cognitive task analysis (CTA) can yield valuable insights into healthcare professionals' cognition and inform system design to promote safe, quality care. Our objective was to adapt CTA-the critical decision method, specifically-to investigate patient safety incidents, overcome barriers to implementing this method, and facilitate more widespread use of cognitive task analysis in healthcare.
METHODS: We adapted CTA to facilitate recruitment of healthcare professionals and developed a data collection tool to capture incidents as they occurred. We also leveraged the electronic health record (EHR) to expand data capture and used EHR-stimulated recall to aid reconstruction of safety incidents. We investigated 3 categories of medication-related incidents: adverse drug reactions, drug-drug interactions, and drug-disease interactions. Healthcare professionals submitted incidents, and a subset of incidents was selected for CTA. We analyzed several outcomes to characterize incident capture and completed CTA interviews.
RESULTS: We captured 101 incidents. Eighty incidents (79%) met eligibility criteria. We completed 60 CTA interviews, 20 for each incident category. Capturing incidents before interviews allowed us to shorten the interview duration and reduced reliance on healthcare professionals' recall. Incorporating the EHR into CTA enriched data collection.
CONCLUSIONS: The adapted CTA technique was successful in capturing specific categories of safety incidents. Our approach may be especially useful for investigating safety incidents that healthcare professionals "fix and forget." Our innovations to CTA are expected to expand the application of this method in healthcare and inform a wide range of studies on clinical decision making and patient safety.

Entities:  

Mesh:

Year:  2019        PMID: 28471774     DOI: 10.1097/PTS.0000000000000324

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.844


  5 in total

1.  Barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer: what's the problem?

Authors:  Clint Cary; Laura Militello; Paige DeChant; Richard Frankel; Michael O Koch; Michael Weiner
Journal:  Urol Pract       Date:  2021-03-01

2.  Care Coordination Strategies and Barriers during Medication Safety Incidents: a Qualitative, Cognitive Task Analysis.

Authors:  Alissa L Russ-Jara; Cherie L Luckhurst; Rachel A Dismore; Karen J Arthur; Amanda P Ifeachor; Laura G Militello; Peter A Glassman; Alan J Zillich; Michael Weiner
Journal:  J Gen Intern Med       Date:  2021-01-21       Impact factor: 6.473

3.  Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: a qualitative, cognitive task analysis.

Authors:  Nervana Elkhadragy; Amanda P Ifeachor; Julie B Diiulio; Karen J Arthur; Michael Weiner; Laura G Militello; Peter A Glassman; Alan J Zillich; Alissa L Russ
Journal:  BMJ Open       Date:  2019-05-24       Impact factor: 2.692

4.  Strategies prescribers and pharmacists use to identify and mitigate adverse drug reactions in inpatient and outpatient care: a cognitive task analysis at a US Veterans Affairs Medical Center.

Authors:  Khoa Anh Nguyen; Laura G Militello; Amanda Ifeachor; Karen J Arthur; Peter A Glassman; Alan J Zillich; Michael Weiner; Alissa L Russ-Jara
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

5.  Effect of a Template Case Report Based on Cognitive Task Analysis on Emergency Thinking Ability of Resident Doctors in Standardized Training.

Authors:  Hui Guo; Hui-Jun Qi; Xu-Rui Li; Ning Xu; Qian Zhao; Zhang-Shun Shen; Yang-Juan Jia; Jian-Guo Li
Journal:  Patient Prefer Adherence       Date:  2021-07-15       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.